Harvard Bioscience (HBIO) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.07% |
| Dec 31, 2025 | -0.70% |
| Sep 30, 2025 | -19.43% |
| Jun 30, 2025 | -23.13% |
| Mar 31, 2025 | 1.17% |
| Dec 31, 2024 | 13.19% |
| Sep 30, 2024 | 7.77% |
| Jun 30, 2024 | 3.72% |
| Mar 31, 2024 | 3.29% |
| Dec 31, 2023 | 11.75% |
| Sep 30, 2023 | 4.32% |
| Jun 30, 2023 | 5.12% |
| Mar 31, 2023 | 8.76% |
| Dec 31, 2022 | 4.69% |
| Sep 30, 2022 | 2.49% |
| Jun 30, 2022 | 2.05% |
| Mar 31, 2022 | -3.39% |
| Dec 31, 2021 | -6.92% |
| Sep 30, 2021 | -0.75% |
| Jun 30, 2021 | -11.43% |
| Mar 31, 2021 | -6.85% |
| Dec 31, 2020 | -4.28% |
| Sep 30, 2020 | 14.36% |
| Jun 30, 2020 | 15.47% |
| Mar 31, 2020 | 6.04% |
| Dec 31, 2019 | 10.02% |
| Sep 30, 2019 | 23.85% |
| Jun 30, 2019 | 28.52% |
| Mar 31, 2019 | 27.91% |
| Dec 31, 2018 | 20.85% |
| Sep 30, 2018 | 20.28% |
| Jun 30, 2018 | 31.37% |
| Mar 31, 2018 | 24.08% |
| Dec 31, 2017 | 22.63% |
| Sep 30, 2017 | 22.06% |
| Jun 30, 2017 | 24.02% |
| Mar 31, 2017 | 23.77% |
| Dec 31, 2016 | 20.76% |
| Sep 30, 2016 | 19.93% |
| Jun 30, 2016 | 30.09% |
| Mar 31, 2016 | 26.96% |
| Dec 31, 2015 | 19.30% |
| Sep 30, 2015 | 18.77% |
| Jun 30, 2015 | 17.27% |